CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The products will be manufactured at the company's facility in Bengaluru
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The hospital hosted a two-day event with top internal and external faculty and medical experts
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The products will be manufactured at the company's facility in Bengaluru
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Subscribe To Our Newsletter & Stay Updated
